Articles by Daniel Marsh
Salmonella Outbreak Tied to 98 Cases, Egg Recall Minimal for Supply
A salmonella outbreak linked to Midwest Poultry Services eggs has sickened 98 people across 17 states, with 26 hospitalized. The recall of 1.59 million dozen eggs is minimal relative to U.S. output, but brand risks for Kroger and Cal-Maine Foods remain.
CoreWeave Stock Slips as AI Spending Concerns Weigh on Markets
CoreWeave shares slipped 11.4% on Friday as AI funding concerns persisted, while IREN and Nebius posted weekly gains. Alphabet's capex hike and Google Cloud's 82% revenue growth underscored industry cash flow dynamics.
WBD Stock Discount Widens Beyond Regulatory Delay Fee
WBD shares ended Friday at $25.77, creating a $5.23 gap from the $31 takeover offer, far exceeding the ticking fee of $0.68 per share.
Plug Power Dips 4.6% as $50M Texas Sale Nears Liquidity Inflection
Plug Power (PLUG) closed 4.6% lower at $2.09 on Friday. The company expects $50 million from its Texas project by July 31, a key liquidity event.
STAK Inc. Stock Surges 278% as Trading Volume Exceeds Outstanding Shares by 4x
STAK Inc. shares surged 278% to $4.99, with trading volume of 42.3 million shares exceeding its 10.01 million Class A shares by over four times, despite no recent company announcements.
Outlook Therapeutics Halts After Lytenava Approval; Cash Concerns Loom
Outlook Therapeutics (OTLK) shares were suspended after FDA approval of Lytenava for wet AMD. The stock rose 23.5% to $1.63, but funding from warrants and cash burn remain key issues.
Apple Surges 3.5% as Low-Capex AI Strategy Attracts Premium Valuation
Apple shares rose 3.5% to $332.87 as its capital-light AI model attracts investors, with cash flow after property purchases at $78.28 billion, far exceeding Alphabet's $4.26 billion.
Alibaba Loses HK$94B as AI Rally Fades, Underperforms Peers
Alibaba shares fell 4.26% on Friday, wiping out HK$94 billion in market value as enthusiasm for an AI-driven rally subsided. The stock underperformed peers like JD.com and Meituan.